CompletedNot Applicable

Prediction of BK Virus Reactivation in Kidney Transplant Recipient

Thailand80 participantsStarted 2023-05-01

Plain-language summary

There has been no effective predicting tool to accurately predict BKV reactivation after kidney transplantation. The aim is to elucidate the use of flow cytometric analysis for both intracellular cytokines and surface activation markers for BKV-specific T cell response in kidney transplant recipients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. New kidney transplantation cases (either living donor or deceased donor transplantation)
✓. Age ≥ 18 years old
✓. Agree to give a permission to blood sampling post-transplantation, and at the time of BK viremia.

Exclusion criteria

✕. Pregnant
✕. Primary non-function of kidney allograft (i.e. kidney allograft never function).

What they're measuring

BKV-specific immune response

Timeframe: Day 30, Day 90 after transplantation before BK viremia

Trial details

NCT IDNCT06219616

SponsorKing Chulalongkorn Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-30

View on ClinicalTrials.gov More Kidney Transplant Infection trials